State Street’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Buy |
719,212
+5,138
| +0.7% | +$17.3K | ﹤0.01% | 3243 |
|
|
2025
Q1 | $2.76M | Sell |
714,074
-9,245
| -1% | -$35.7K | ﹤0.01% | 3126 |
|
|
2024
Q4 | $4.46M | Buy |
723,319
+32,493
| +5% | +$200K | ﹤0.01% | 3023 |
|
|
2024
Q3 | $3.72M | Sell |
690,826
-4,597
| -0.7% | -$24.7K | ﹤0.01% | 3095 |
|
|
2024
Q2 | $2.33M | Sell |
695,423
-3,563
| -0.5% | -$11.9K | ﹤0.01% | 3262 |
|
|
2024
Q1 | $2.82M | Buy |
698,986
+3,762
| +0.5% | +$15.2K | ﹤0.01% | 3166 |
|
|
2023
Q4 | $1.84M | Buy |
695,224
+2,501
| +0.4% | +$6.63K | ﹤0.01% | 3337 |
|
|
2023
Q3 | $1.63M | Buy |
692,723
+106,688
| +18% | +$252K | ﹤0.01% | 3405 |
|
|
2023
Q2 | $3.69M | Sell |
586,035
-125,493
| -18% | -$791K | ﹤0.01% | 3148 |
|
|
2023
Q1 | $4.11M | Sell |
711,528
-2,325,932
| -77% | -$13.4M | ﹤0.01% | 3066 |
|
|
2022
Q4 | $31.2M | Buy |
3,037,460
+2,127,991
| +234% | +$21.8M | ﹤0.01% | 1936 |
|
|
2022
Q3 | $15.2M | Buy |
909,469
+459,688
| +102% | +$7.69M | ﹤0.01% | 2428 |
|
|
2022
Q2 | $6.3M | Buy |
449,781
+46,240
| +11% | +$647K | ﹤0.01% | 2980 |
|
|
2022
Q1 | $6.52M | Buy |
403,541
+61,280
| +18% | +$990K | ﹤0.01% | 3044 |
|
|
2021
Q4 | $7.33M | Buy |
342,261
+130,653
| +62% | +$2.8M | ﹤0.01% | 3062 |
|
|
2021
Q3 | $3.11M | Buy |
211,608
+23,519
| +13% | +$346K | ﹤0.01% | 3484 |
|
|
2021
Q2 | $3.74M | Buy |
+188,089
| New | +$3.74M | ﹤0.01% | 3375 |
|